Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial-Reference-Cited by-同舟云学术

Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial

Published:2014-10-15 Issue:5 Volume:171 Page:1215-1219
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Zhu B.¹,Edson‐Heredia E.¹,Guo J.²,Maeda‐Chubachi T.¹,Shen W.¹,Kimball A.B.³

Affiliation:

1. Eli Lilly and Company Indianapolis IN U.S.A

2. inVentiv Health Clinical Indianapolis IN U.S.A

3. Massachusetts General Hospital Boston MA U.S.A

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.13065

Reference17 articles.

1. Concordance of the Psoriasis Area and Severity Index (PASI) and patient‐reported outcomes in psoriasis treatment;Schäfer I;Eur J Dermatol,2010

2. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab

3. Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque Psoriasis

4. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies

5. European Dermatology Forum. (2009)EDF guidelines for dermatology in Europe. Available at:http://www.abw-verlag.com/db_picture.php?120;BOOKS_BookList;Leseprobe(last accessed 1 October 2014).

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Itch and pain are major components of psoriatic disease and require management;Medicom Conference Report IFPA 2024;2024-07-17

2. Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States;Dermatology and Therapy;2024-06-14

3. Association of pruritus with sleep in patients with psoriasis and chronic spontaneous urticaria: A cross-sectional study;Journal of Family Medicine and Primary Care;2023-09

4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

5. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate‐to‐severe plaque psoriasis patients in conditions close to clinical practice;Journal of the European Academy of Dermatology and Venereology;2023-06-13